Logo image of GSV

GOLD STANDARD VENTURES CORP (GSV) Stock Fundamental Analysis

USA - NYSEARCA:GSV - CA3807381049 - Common Stock

0.402 USD
+0 (+0.5%)
Last: 8/11/2022, 8:04:01 PM
0.382 USD
-0.02 (-4.98%)
After Hours: 8/11/2022, 8:04:01 PM
Fundamental Rating

2

GSV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. While GSV seems to be doing ok healthwise, there are quite some concerns on its profitability. GSV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GSV had negative earnings in the past year.
GSV Yearly Net Income VS EBIT VS OCF VS FCFGSV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 -10M -20M -30M -40M

1.2 Ratios

Industry RankSector Rank
ROA -3.34%
ROE N/A
ROIC -2.58%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSV Yearly ROA, ROE, ROICGSV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -2 -4 -6

1.3 Margins

GSV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GSV Yearly Profit, Operating, Gross MarginsGSV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021

More info and screens

4

2. Health

2.1 Basic Checks

GSV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GSV has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, GSV has an improved debt to assets ratio.
GSV Yearly Shares OutstandingGSV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
GSV Yearly Total Debt VS Total AssetsGSV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 18.38 indicates that GSV is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.00 indicates that GSV is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.38
ROIC/WACC-0.27
WACC9.62%
GSV Yearly LT Debt VS Equity VS FCFGSV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M

2.3 Liquidity

GSV has a Current Ratio of 21.71. This indicates that GSV is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 21.71 indicates that GSV has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 21.71
Quick Ratio 21.71
GSV Yearly Current Assets VS Current LiabilitesGSV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

GSV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.67%, which is quite impressive.
EPS 1Y (TTM)31.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, GSV will show a very strong growth in Earnings Per Share. The EPS will grow by 27.97% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y40.59%
EPS Next 2Y1.71%
EPS Next 3Y42.46%
EPS Next 5Y27.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSV Yearly Revenue VS EstimatesGSV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 -100K -200K -300K
GSV Yearly EPS VS EstimatesGSV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.02 -0.02 0.04 -0.04 -0.06

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GSV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GSV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSV Price Earnings VS Forward Price EarningsGSV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -18.8
GSV Per share dataGSV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

GSV's earnings are expected to grow with 42.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.71%
EPS Next 3Y42.46%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GSV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GOLD STANDARD VENTURES CORP

NYSEARCA:GSV (8/11/2022, 8:04:01 PM)

After market: 0.382 -0.02 (-4.98%)

0.402

+0 (+0.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-03 2022-08-03
Earnings (Next)11-08 2022-11-08
Inst Owners0.41%
Inst Owner Change-19.26%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap144.21M
Analysts77.78
Price Target0.72 (79.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB N/A
EV/EBITDA -18.8
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.6
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.34%
ROE N/A
ROCE N/A
ROIC -2.58%
ROICexc N/A
ROICexgc -2.58%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 21.71
Quick Ratio 21.71
Altman-Z 18.38
F-Score6
WACC9.62%
ROIC/WACC-0.27
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y40.59%
EPS Next 2Y1.71%
EPS Next 3Y42.46%
EPS Next 5Y27.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A